Business Description
![Theriva Biologics Inc Theriva Biologics Inc logo](https://static.gurufocus.com/logos/0C00000DU8.png?14)
Theriva Biologics Inc
NAICS : 325412
SIC : 2834
ISIN : US87164U1025
Description
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.
Financial Strength
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 9.05 | |||||
Equity-to-Asset | 0.7 | |||||
Debt-to-Equity | 0.06 | |||||
Debt-to-EBITDA | -0.09 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 36.8 | |||||
3-Year EPS without NRI Growth Rate | 44.3 | |||||
3-Year FCF Growth Rate | 42.9 |
Momentum Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 49.91 | |||||
9-Day RSI | 41.68 | |||||
14-Day RSI | 37.5 | |||||
6-1 Month Momentum % | -37.94 | |||||
12-1 Month Momentum % | -70 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 3.6 | |||||
Quick Ratio | 3.6 | |||||
Cash Ratio | 3.04 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -80.3 | |||||
Shareholder Yield % | -7.61 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -44.06 | |||||
ROA % | -31.85 | |||||
ROIC % | -66.13 | |||||
ROC (Joel Greenblatt) % | -979.95 | |||||
ROCE % | -41.7 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 0.13 | |||||
Price-to-Tangible-Book | 0.63 | |||||
EV-to-EBIT | 0.43 | |||||
EV-to-EBITDA | 0.44 | |||||
EV-to-FCF | 0.51 | |||||
Price-to-Net-Current-Asset-Value | 0.95 | |||||
Price-to-Net-Cash | 1.13 | |||||
Earnings Yield (Greenblatt) % | 232.56 | |||||
FCF Yield % | -449.17 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with AMEX:TOVX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Theriva Biologics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | |||
EPS (TTM) ($) | -1.16 | ||
Beta | 1.16 | ||
Volatility % | 71.9 | ||
14-Day RSI | 37.5 | ||
14-Day ATR ($) | 0.020236 | ||
20-Day SMA ($) | 0.244335 | ||
12-1 Month Momentum % | -70 | ||
52-Week Range ($) | 0.1972 - 0.85 | ||
Shares Outstanding (Mil) | 17.28 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Theriva Biologics Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Theriva Biologics Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Theriva Biologics Inc Frequently Asked Questions
What is Theriva Biologics Inc(TOVX)'s stock price today?
The current price of TOVX is $0.24. The 52 week high of TOVX is $0.85 and 52 week low is $0.20.
When is next earnings date of Theriva Biologics Inc(TOVX)?
The next earnings date of Theriva Biologics Inc(TOVX) is 2024-08-08 Est..
Does Theriva Biologics Inc(TOVX) pay dividends? If so, how much?
Theriva Biologics Inc(TOVX) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |